Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 6/20 | 0.58 |
| ▸ | BRS3 | P32247 | 3/20 | 0.57 |
| ▸ | TACR1 | P25103 | 2/20 | 0.57 |
| ▸ | TACR3 | P29371 | 1/20 | 0.57 |
| ▸ | CTSL | P07711 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | BID | P55957 | 1/20 | 0.53 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17870487 | 1.00 | NMBR (0.58) | NMBRBRS3TACR1TACR3CTSL | |
| SCHEMBL17870210 | 0.91 | NMBR (0.60) | NMBRBRS3TACR1TACR3CTSL | |
| SCHEMBL17884327 | 0.85 | CTSL (0.72) | NMBRTACR1TACR3CTSL | |
| SCHEMBL3782261 | 0.80 | KMT2A (0.66) | TACR1CTSLALOX15 | |
| SCHEMBL3787557 | 0.80 | MMP9 (0.72) | ALOX15 | |
| SCHEMBL17941644 | 0.80 | MMP2 (0.74) | NMBRTACR3 | |
| SCHEMBL17941642 | 0.80 | MMP2 (0.74) | NMBRTACR3 | |
| SCHEMBL3857229 | 0.80 | ALOX15 (0.74) | ALOX15 | |
| SCHEMBL3857226 | 0.80 | ALOX15 (0.74) | ALOX15 | |
| Hydrochloric Acid SCHEMBL20511898 | 0.79 | KMT2A (0.65) | TACR1CTSLALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180265547-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-09-20 | — | — | US | disclosed |
| US-20160185821-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185821-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | QPCT, PTMS, MAX | NMBR 678/4885BRS3 852/4885TACR1 598/4885 |
| US-20180265547-A1 | Z-SELECTIVE OLEFIN METATHESIS OF PEPTIDES | QPCT, PTMS, MAX | NMBR 678/4885BRS3 852/4885TACR1 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.